We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.22B
AUM Growth
+$217M
Cap. Flow
-$36.1M
Cap. Flow %
-0.85%
Top 10 Hldgs %
10.67%
Holding
338
New
31
Increased
82
Reduced
135
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Healthcare 19.99%
3 Industrials 15.5%
4 Financials 12.04%
5 Consumer Discretionary 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCRA
126
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$15.2M 0.36%
416,373
-57,720
-12% -$1.89M
DY icon
127
Dycom Industries
DY
$12B
$15.1M 0.36%
178,152
+4,719
+3% +$408K
VIRT icon
128
Virtu Financial
VIRT
$4.92B
$14.6M 0.35%
712,245
+18,822
+3% +$429K
FLXN
129
DELISTED
Flexion Therapeutics, Inc.
FLXN
$14.6M 0.34%
777,775
+111,615
+17% +$2.56M
TYL icon
130
Tyler Technologies
TYL
$13B
$14.5M 0.34%
59,221
-8
-0% -$1.9K
JELD icon
131
JELD-WEN Holding
JELD
$162M
$14.4M 0.34%
585,897
+15,470
+3% +$412K
VRSK icon
132
Verisk Analytics
VRSK
$23.6B
$14M 0.33%
116,513
-20
-0% -$2.33K
IONS icon
133
Ionis Pharmaceuticals
IONS
$9.46B
$13.9M 0.33%
269,382
-57,383
-18% -$2.7M
NVTR
134
DELISTED
Nuvectra Corporation Common Stock
NVTR
$13.1M 0.31%
+597,809
New +$11.5M
IT icon
135
Gartner
IT
$12.2B
$12.9M 0.31%
81,200
NTRA icon
136
Natera
NTRA
$45.9B
$12.8M 0.3%
+535,953
New +$13M
ICPT
137
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12.6M 0.3%
99,938
-51,496
-34% -$5.45M
BRY
138
DELISTED
Berry Corp
BRY
$12.5M 0.3%
+707,479
New +$10.5M
ZUO
139
DELISTED
Zuora, Inc.
ZUO
$12.3M 0.29%
+533,660
New +$14.2M
BFYT
140
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$12.2M 0.29%
197,489
-35,109
-15% -$1.6M
BKNG icon
141
Booking.com
BKNG
$160B
$12.2M 0.29%
153,275
CERS icon
142
Cerus
CERS
$508M
$12M 0.29%
1,669,219
-336,346
-17% -$2.44M
CUTR
143
DELISTED
Cutera, Inc.
CUTR
$12M 0.28%
368,758
+2,666
+0.7% +$97.2K
ONTO icon
144
Onto Innovation
ONTO
$14.5B
$11.9M 0.28%
318,028
+8,257
+3% +$325K
ICFI icon
145
ICF International
ICFI
$1.66B
$11.9M 0.28%
157,717
+4,176
+3% +$320K
AXGN icon
146
Axogen
AXGN
$2.59B
$11.8M 0.28%
+321,499
New +$14M
MKTX icon
147
MarketAxess Holdings
MKTX
$5.72B
$11.4M 0.27%
63,762
HMHC
148
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$11.1M 0.26%
1,589,549
+95,368
+6% +$643K
PGEN icon
149
Precigen
PGEN
$2.51B
$11.1M 0.26%
645,815
-65,451
-9% -$973K
PCRX icon
150
Pacira BioSciences
PCRX
$974M
$11M 0.26%
224,747
-45,826
-17% -$1.98M

Similar funds

Peregrine Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Peregrine Capital Management held 338 positions worth $4.22B, up 5.4% from $4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Peregrine Capital Management's Q3 2018 filing shows 31 new, 82 increased, 135 reduced and 23 closed positions. Its largest new stake was Element Solutions: 1,956,650 shares worth $24.4M. The largest sale was NEVRO CORP., an estimated $29.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Peregrine Capital Management's largest Q3 2018 buy was Element Solutions: 1,956,650 shares worth $24.4M.
  • Peregrine Capital Management added most to Beacon Roofing Supply, Inc. in Q3 2018, an estimated $14.3M increase.
  • Peregrine Capital Management's biggest Q3 2018 reduction was Skechers, cutting an estimated $24M.
  • Peregrine Capital Management fully exited NEVRO CORP. in Q3 2018, selling an estimated $29.7M.
  • Peregrine Capital Management's ten largest holdings make up 11% of its $4.22B portfolio in Q3 2018.
  • Peregrine Capital Management opened 31 new positions and closed 23 in Q3 2018.
  • Peregrine Capital Management's portfolio value rose 5.4% quarter-over-quarter to $4.22B.

Based on Peregrine Capital Management's 13F filing for Q3 2018, filed 18 Oct 2018.